Analysts' ratings for Inari Medical (NASDAQ:NARI) over the last quarter vary from bullish to bearish, as provided by 6 analysts. The following table encapsulates their recent ratings, offering a ...

We recently compiled a list of the Investor Optimism Boosts Jump of These 10 Stocks. In this article, we are going to take a ...

Oppenheimer initiated coverage of Inari Medical (NARI) with an Outperform rating and $75 price target Inari is a leader in the thrombectomy for the treatment of deep vein thrombosis and pulmonary ...

Baird R W cut shares of Inari Medical (NASDAQ:NARI – Free Report) from a strong-buy rating to a hold rating in a research ...

Inari Medical (NASDAQ:NARI – Free Report) had its price target increased by Piper Sandler from $52.00 to $80.00 in a report ...

Stryker announces agreement to acquire Inari Medical for $4.9 billion, resulting in a 21% jump in Inari's shares.

Inari Medical's stock surged 6% amid reports of advanced acquisition talks with Stryker, potentially closing a deal this week ...

Despite a lackluster performance from Wall Street’s major indices, 10 companies demonstrated notable resilience.

Shares of Inari Medical, Inc. (NASDAQ:NARI – Get Free Report) have received an average rating of “Moderate Buy” from the ...

Inari Medical (NARI – Research Report) received a Hold rating and price target from BTIG analyst Marie Thibault today. The company’s shares ...

We recently published a list of 10 Firms Post Strong Gains Amid Wall Street Bloodbath. In this article, we are going to take ...

Inari Medical (NASDAQ:NARI – Get Free Report)‘s stock had its “neutral” rating reaffirmed by Robert W. Baird in a research note issued to investors on Tuesday,Benzinga reports. They presently have a ...